Perinatology.  2019 Mar;30(1):32-35. 10.14734/PN.2019.30.1.32.

Antepartum Diagnosis and Treatment of Diffuse Alveolar Hemorrhage in a Pregnant Woman with Systemic Lupus Erythematosus

Affiliations
  • 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea. smleemd@hanmail.net
  • 2Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
  • 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • 4Department of Obstetrics and Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.

Abstract

Diffuse alveolar hemorrhage (DAH) is a rare and life-threatening complication of systemic lupus erythematosus. Differential diagnosis and successful management of DAH can be problematic in pregnancy. We report a case of a 35-year-old pregnant woman who was presumptively diagnosed with DAH and treated during the antepartum period, resulting in symptomatic improvement and successful delivery after immunosuppressive treatment.

Keyword

Pregnancy complications; Lupus erythematosus; Systemic; Lupus nephritis; Hemorrhage; Lung diseases

MeSH Terms

Adult
Diagnosis*
Diagnosis, Differential
Female
Hemorrhage*
Humans
Lung Diseases
Lupus Erythematosus, Systemic*
Lupus Nephritis
Pregnancy
Pregnancy Complications
Pregnant Women*

Figure

  • Fig. 1. (A) Chest radiograph showing diffuse consolidation. (B) Chest computed tomography scan showing diffuse ground glass opacity and nodular consolidation.

  • Fig. 2. Chest radiograph showing radiographic improvement.


Reference

References

1. Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010; 137:1164–71.
Article
2. Martínez-Martínez MU, Abud-Mendoza C. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Clinical manifestations, treatment, and prognosis. Reumatol Clin. 2014; 10:248–53.
Article
3. Kamen DL, Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med. 2010; 31:479–88.
Article
4. Pego-Reigosa JM, Medeiros DA, Isenberg DA. Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract Res Clin Rheumatol. 2009; 23:469–80.
Article
5. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997; 76:192–202.
Article
6. Barile LA, Jara LJ, Medina-Rodriguez F, García-Figueroa JL, Miranda-Limón JM. Pulmonary hemorrhage in systemic lupus erythematosus. Lupus. 1997; 6:445–8.
Article
7. Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest. 2000; 118:1083–90.
8. Mitchell K, Kaul M, Clowse ME. The management of rheumatic diseases in pregnancy. Scand J Rheumatol. 2010; 39:99–108.
Article
9. Erickson RW, Franklin WA, Emlen W. Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum. 1994; 24:114–23.
Article
10. Takada K, Illei GG, Boumpas DT. Cyclophosphamide for the treatment of systemic lupus erythematosus. Lupus. 2001; 10:154–61.
Article
11. Martínez-Martínez MU, Abud-Mendoza C. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus. 2011; 20:568–74.
Article
12. Gaither K, Halstead K, Mason TC. Pulmonary alveolar hemorrhage in a pregnancy complicated by systemic lupus erythematosus. J Natl Med Assoc. 2005; 97:831–3.
13. Keane MP, Van De Ven CJ, Lynch JP 3rd, McCune WJ. Systemic lupus during pregnancy with refractory alveolar haemorrhage: recovery following termination of pregnancy. Lupus. 1997; 6:730–3.
Article
14. Blitz MJ, Fleischer A. Severe maternal morbidity associated with systemic lupus erythematosus flare in the second trimester of pregnancy. Case Rep Obstet Gynecol. 2018; 2018:5803479.
Article
Full Text Links
  • PN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr